GYRE THERAPEUTICS, INC. - GYRE

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 23
Latest filed: May 22, 2026
Form Count
4 9
8-K 9
SCHEDULE 13D/A 3
144 1
8-K/A 1

Latest files

Filed Form Report period Accession SEC
May 22, 2026 4 May 20, 2026 0001140361-26-022642 View
May 20, 2026 4 May 14, 2026 0001140361-26-022303 View
May 20, 2026 4 May 18, 2026 0001140361-26-022235 View
May 18, 2026 4 May 14, 2026 0001140361-26-021889 View
May 14, 2026 8-K May 14, 2026 0001140361-26-021360 View
May 12, 2026 8-K May 12, 2026 0001140361-26-020845 View
May 11, 2026 144 — 0001985496-26-000001 View
May 07, 2026 4 May 05, 2026 0001140361-26-019658 View
May 07, 2026 SCHEDULE 13D/A — 0001140361-26-019395 View
May 07, 2026 8-K May 07, 2026 0001193125-26-209789 View
May 06, 2026 SCHEDULE 13D/A — 0001140361-26-019388 View
May 06, 2026 4 May 04, 2026 0001140361-26-019376 View
May 06, 2026 4 May 04, 2026 0001140361-26-019378 View
May 06, 2026 SCHEDULE 13D/A — 0001140361-26-019380 View
May 04, 2026 8-K May 04, 2026 0001140361-26-018716 View
Apr 17, 2026 8-K/A Mar 02, 2026 0001140361-26-015307 View
Mar 23, 2026 8-K Mar 22, 2026 0001140361-26-010654 View
Mar 12, 2026 8-K Mar 12, 2026 0001193125-26-102700 View
Mar 12, 2026 8-K Mar 10, 2026 0001140361-26-009115 View
Mar 02, 2026 8-K Mar 02, 2026 0001140361-26-007249 View
Jan 09, 2026 4 Jan 07, 2026 0001140361-26-000831 View
Jan 09, 2026 4 Jan 07, 2026 0001140361-26-000832 View
Jan 05, 2026 8-K Jan 05, 2026 0001140361-26-000253 View